Wenlu Li

Title: Wenlu Li: Pioneering Cancer Research Through Innovative Patents

Introduction:

In the realm of cutting-edge cancer research, few names stand out like that of Wenlu Li. Based in South San Francisco, California, Wenlu Li has made significant contributions to the field through his innovative patents and groundbreaking research. This article delves into his latest patents, career highlights, collaborations, and his role at Diadexus, Inc.

Latest Patents:

Wenlu Li's groundbreaking work centers around the development of isolated antibodies that target specific cancer antigens. His latest patents include:

1. Ovr115 Antibody Compositions and Methods of Use: This invention involves isolated anti-Ovr115 antibodies that bind to Ovr115, a specific cancer antigen found in ovarian, pancreatic, lung, or breast cancer cells. The patent encompasses various aspects, including isolated nucleic acids, expression vectors, and methods for producing and using anti-Ovr115 antibodies for cancer treatment.

2. Pro104 Antibody Compositions and Methods of Use: This patent focuses on isolated anti-Pro104 antibodies that target Pro104, another cancer antigen present in ovarian, pancreatic, lung, or breast cancer cells. It covers compositions, nucleic acids, vectors, and methods for producing and utilizing anti-Pro104 antibodies for cancer therapy.

Career Highlights:

Beyond his remarkable patents, Wenlu Li has a stellar career trajectory. With a strong foundation in scientific research, his work has the potential to revolutionize cancer treatment. His career highlights include:

- Extensive Experience: Wenlu Li possesses a wealth of experience in cancer research and has actively contributed to the development of novel therapeutic approaches.

- Research Leadership: As a key member of Diadexus, Inc., Wenlu Li has played an instrumental role in leading and guiding the company's research efforts. His expertise has shaped their innovative directions and contributed to advancements in cancer treatment.

Collaborations:

Wenlu Li's collaborative efforts with esteemed colleagues have greatly enriched his research. Notable collaborators include Glenn Ronald Pilkington and Gilbert-Andre Keller. These collaborations demonstrate the interdisciplinary and collaborative nature of scientific research, fostering the exchange of ideas and driving progress in the field.

Conclusion:

Wenlu Li's accomplishments in the field of cancer research are truly remarkable. With his extensive experience, groundbreaking patents, and leadership in the industry, he continues to push boundaries and drive advancements in cancer treatment. Wenlu Li's dedication serves as an inspiration to aspiring researchers and underscores the importance of innovation in the ongoing fight against cancer.

Disclaimer: The information presented in this article is based on publicly available data and is intended for informational purposes only. Please note that the patents mentioned are subject to change, and it is advised to refer to official patent databases for the most up-to-date information.